SINGLE SHOT CHAMPION

A phase 4 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 210 participants.

Also called NCT05534581

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 210 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT05534581
Other papers using this trial's data
  • Pulsed Field or Cryoballoon Ablation for Paroxysmal Atrial Fibrillation The New England journal of medicine, 2025-04-17 DOI, PubMed 40162734

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Switzerland (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT05534581. Randomized; no masking; primary purpose treatment. Start 2022-09-26 (actual); primary completion 2025-01-01 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
SINGLE SHOT CHAMPION
Condition
Paroxysmal Atrial Fibrillation
Intervention (Device)
PVI using the Arctic Front Cryoballoon (Medtronic)
Intervention (Device)
PVI using FARAPULSE Pulsed Field Ablation (Boston Scientific)
Lead sponsor
Insel Gruppe AG, University Hospital Bern (class: other)
Collaborator
University of Bern (class: other)

Record details

Record id
cardio:ct-nct05534581
Content hash
1191dfdeb297ace7d922dafbe8aa661e0b153fa0e2103244981b2b373ac1e5ca